2024 Encephalitis Diagnostics Market: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment--US, Europe, Japan--Hospitals, Commercial and Public Health Labs, POC Locations
The report presents a detailed analysis of the Encephalitis diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology are reviewed.
The report is available by section, and can be customized to specific information needs and budget.
The report provides the 5-year test volume and sales forecasts by country for the following market segments:
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
List of Tables
Major Companies Developing or Marketing Encephalitis Tests
France Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
Companies Profiled
Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako